Stauber granted distribution rights for Bimuno
Clasado Biosciences granted Stauber non-exclusive rights to distribute its Bimuno prebiotic ingredient.
Photo © iStockphoto.com
Clasado Biosciences (Reading, UK), an international biotechnology company that develops prebiotics and gut-health solutions, granted Stauber (Fullerton, CA) non-exclusive rights to distribute its Bimuno prebiotic ingredient. Bimuno uses a proprietary galactooligosaccharides (GOS) mixture to feed and stimulate the growth of bifidobacterial.
“We share the belief that science-backed digestive health should be effective and accessible to everyone,” said Per Rehné, CEO at Clasado Biosciences, in a press release. “Consumers are seeking new ways to bolster and support the wider functions of the body, and Bimuno is a demonstrable way to do this. The North American market is one of the fastest growing geographies for prebiotic supplements, and we’re excited about the opportunity that lies ahead for Clasado to grow in this region.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
